Why These 10 Stocks Soared Today

The stock market rebounded on Wednesday, with all major indices ending in the green as investors cheered the Federal Reserve’s decision to keep interest rates unchanged.

On Wednesday afternoon, the Fed kept rates steady at a range of 4.25 percent to 4.5 percent, saying that it was not in a hurry to cut rates and could still “wait and see” the impact of President Donald Trump’s tariff policies.

The Dow Jones rallied by 0.70 percent, the S&P 500 increased by 0.43 percent, and the Nasdaq grew by 0.27 percent.

Beyond the major indices, 10 firms stood out with strong gains, thanks to a flurry of fresh developments, including new partnerships, optimistic outlooks, and impressive earnings performance. In this article, we name Wednesday’s 10 best-performing stocks and detail the reasons behind their gains.

To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume.

Photo by Jonathan Borba on Pexels

10. Webull Corporation (NASDAQ:BULL)

Webull Corporation saw its share prices rise by 8.77 percent to finish at $16.25 each as investor sentiment was boosted by the company’s new collaboration with Visa to enable real-time transactions in the US.

Under the partnership, accessing and transferring funds to and from Webull accounts will now be made easier in less than a minute with Visa Direct, compared to traditional methods like Automated Clearing House (ACH) transfers, which take days.

In a statement, Webull Corporation (NASDAQ:BULL) President Anthony Denier said: “We are proud to work with Visa and its expansive network to enhance opportunities within financial markets. There are several exciting uses for this new capability, which will allow us to integrate technology into traditional financial services in ways that better serve Webull’s customers.”

Webull Corporation (NASDAQ:BULL) is a financial services company offering trading platform services for various assets such as stocks and ETFs, among others. It also offers wealth management and investor education services.

9. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Teva Pharmaceutical grew its share prices by 9.18 percent on Wednesday to end at $17.60 apiece as investors cheered the company’s 9th consecutive quarter of impressive revenue performance.

In its earnings release, Teva Pharmaceutical Industries Limited (NYSE:TEVA) said it achieved a 2-percent increase in revenues in the first three months of the year at $3.89 billion from the $3.82 billion registered in the same period last year, thanks to the higher contribution from Austedo and Uzedy’s US operations, coupled with sales from its generic products across all other segments.

The strong figures pushed the company to profitability during the quarter, having swung to an attributable net income of $214 million versus a $139 million net loss year-on-year.

Looking ahead, Teva Pharmaceutical Industries Limited (NYSE:TEVA) posted a generally optimistic outlook for its business, saying that US tariffs are expected to have an immaterial impact.

For the full year 2025, the company expects revenues to settle anywhere between $16.8 billion and $17.2 billion.